Parallax by Ankur Kalra

In this TCT 2021 episode of Parallax, Dr Ankur Kalra’s guest is Prof Mamas Mamas, Consultant Interventional Cardiologist at University Hospitals of North Midlands NHS Trust (UHNM), Professor of Cardiology at Keele University and Senior Clinical Editor of TCTmd.

Ankur invites Mamas to talk about the clinical relevance of some of the top studies presented at TCT 2021. Mamas summarises the studies, some of their salient features and the findings. Ankur and Mamas discuss the strategies they currently apply in their US and UK based practices and share how they think the novel data will guide their decision-making.

What are the questions that emerged from the new data? What are the controversies? How do these trials challenge our current practice?

Trials covered in detail include:

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

EROSION III: A Randomized Trial of OCT-Guided Intervention in STEMI Patients With Early Infarct Artery Patency

OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

Questions and comments can be sent to “[email protected]” and may be answered by Ankur in the next episode. Guest @mmamas1973 hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Brought to you by Edwards: www.edwardstavr.com

Dr. Pandey, a recipient of multiple awards, thinks about himself as a person driven by curiosity rather than passion. He believes that his interest in solving problems helped him to navigate successes and failures as an early-career researcher.

In celebration of Diwali, Dr. Ankur Kalra sat down with Dr. Ambarish Pandey, Assistant Professor at The University of Texas Southwestern Medical School, to talk about his career path and the questions that shaped his decision-making over the years.

In this candid and insightful interview, Ambarish talks about his training in India and the factors that contributed to his decision to continue his work in the US. He shares how preparing for a journal club led him to studying novel epiphenomenon in large data sets, as well as the practical aspects of applying for funding and developing questions.

What is the meaning of success and failure in academic medicine? What are the questions that guide Dr. Pandey? What does he consider key for his success in academic career? What is his message for our listeners?

Questions and comments can be sent to “[email protected]” and may be answered by Ankur in the next episode. Guest @ambarish4786, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Brought to you by Edwards: www.edwardstavr.com

This week’s Parallax in collaboration with the Heart Failure Society of America (HFSA) explores the many ways organisations can embrace the needs of a diverse community and create a culture that can react to the realities of patientcare.

Host Dr Ankur Kalra’s guest is Dr Nancy M. Albert, Immediate Past President of HFSA and Associate Chief Nursing Officer of the Office of Research and Innovation at the Cleveland Clinic.

In this episode, Dr Albert reflects on the society’s work to cater to the needs of its multidisciplinary members. Dr Kalra asks Dr Albert about HFSA vision statement and the different factors that were considered to put words into actions. They discuss the importance of recruiting a diverse group of volunteers. Dr Albert shares her experiences as a mentor and her tips on how to foster talent, including nurses and other advanced practice providers.

How can people get involved with HFSA? What mentorship opportunities are available? How has HFSA fostered deeper involvement of early career members? What is Dr Albert’s message to our listeners?

Questions and comments can be sent to “[email protected]” and may be answered by Ankur in the next episode. Guest @nancy_m_albert hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Brought to you by Edwards: www.edwardstavr.com

In the second ESC 2021 episode of Parallax, Dr Ankur Kalra’s guest is Dr. Mirvat Alasnag, interventional Cardiologist and Director of Catheterization Laboratory at the King Fahad Armed Forces Hospital (KFAFH) in Saudi Arabia. Dr Alasnag was a programme committee member at this year’s ESC and regional PI of one of the late-breaking trials presented.

Ankur invites Mirvat to review the interventional cardiology highlights of the congress. Mirvat summarises the background and latest evidence from the trials and their importance. Ankur and Mirvat discuss the strategies they apply currently and how they think the novel data will guide their decision-making.

Trials covered in detail include:

STOPDAPT-2 ACS: one-month dual antiplatelet therapy followed by clopidogrel monotherapy in acute coronary syndrome

TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest

ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation

RIPCORD 2: does routine pressure wire assessment influence management strategy of coronary angiography for diagnosis of chest pain?

MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

Questions and comments can be sent to “[email protected]” and may be answered by Ankur in the next episode. Guest @mirvatalasnag hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Brought to you by Edwards: www.edwardstavr.com

In this week’s episode Dr Ankur Kalra’s guest is Dr. Purvi Parwani, Director of Women’s Cardiovascular Disease Clinic and Assistant Professor at Loma Linda University Medical Center.

In this special ESC 2021 edition of Parallax, Ankur asks Purvi to review the highlights of the congress. Purvi summarises the design and findings of the trials and their importance in the treatment of patients. Ankur and Purvi discuss how the novel data presented at ESC will inform their practice.

Trials covered in detail include

• SSaSS: Effect of Salt Substitution on Cardiovascular Events and Death,

• STEP: Intensive vs. standard blood pressure control among older hypertensive patients

• EMPEROR-Preserved and Pooled: Effect of empagliflozin on cardiovascular death and heart failure hospitalisations in patients with heart failure with a preserved ejection fraction, with and without diabetes,

• LOOP: Screening for AF with an implantable loop recorder to prevent stroke compared with results of the STROKESTOP trial,

• IAMI: Influenza Vaccination after Myocardial Infarction randomised trial.

What are the take-home messages of ESC 21? How can we utilise the findings in our practice? What are the questions that need further investigation?

Questions and comments can be sent to “[email protected]” and may be answered by Ankur in the next episode. Guest @purviparwani, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Brought to you by Edwards: www.edwardstavr.com

“It was this sense of finally belonging somewhere that sparked my journey to self-love.”

-Nasrien E. Ibrahim, Sparkplug

Being an advanced heart failure and transplant specialist compelled Dr. Ibrahim to look at life from a different perspective: “With transplants you are seeing the extremes of life and death.”

Dr Ankur Kalra’s guest is Dr Nasrien Ezzeldin Ibrahim, Director of Heart Failure Clinical Research at Inova Heart and Vascular Institute and the writer of SPARKPLUG: The Roadmap to Confidently Ignite and Navigate Your Career Without Compromising Your Dreams.

Dr Nasrien E. Ibrahim left Saudi Arabia and moved to Cincinnati, Ohio at age 15, because her expatriate parents wanted to provide the best educational opportunities for their four Sudanese-Egyptian children. The move was heart-breaking for Nasrien, and it took years for her to feel a sense of belonging.

In this candid episode of Parallax, Nasrien and Ankur open up about their experiences of being an immigrant. Ankur asks Nasrien about her journey to medicine. Nasrien shares the lessons she took away from her years under the mentorship of Dr JoAnn Lindenfeld and later, Dr. James Januzzi. Finally, Nasrien shares her recent experience of writing Sparkplug and how she embraced life with its imperfections and found her purpose.

What were the formative experiences of Dr Nasrien E. Ibrahim? What does she think about charity? And what is her message to our listeners?

Questions and comments can be sent to “[email protected]” and may be answered by Ankur in the next episode. Guest @DrNasrien, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Brought to you by Edwards: www.edwardstavr.com

How can we change the language of medicine to set up patients for success? This was one of the questions of Dr Lala when she met a young father with acute heart failure. After talking with him, she replaced the word failure with function. This seemingly small change created a real difference for the patient. How can we create real understanding through words? How can scientific publishing aid diversity, equity and inclusion?

This week’s episode starts a series in collaboration with the Heart Failure Society of America (HFSA). Host, Ankur Kalra’s guests are Robert Mentz and Anuradha Lala Senior Editorial Team of the Journal of Cardiac Failure (JCF), the official journal of the HFSA and the Japanese Heart Failure Society (JHFS).

In this practical and insightful episode, Dr Kalra asks what does diversity, equity, inclusion and belonging mean to the editorial board of JCF and what were the steps taken to put these principles into practice. Dr Mentz and Dr Lala walk us through how they examined existing practices and turned ideas and core values into action, including transparency and diversity, while creating an atmosphere that is open to innovation.

How can we mandate diverse authorship? What prompted JCF to introduce an early career section? How can we stand by what we are putting forth?

Questions and comments can be sent to “[email protected]” and may be answered by Ankur in the next episode. Guests @robmentz & @dranulala, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Brought to you by Edwards: www.edwardstavr.com

The views expressed in this episode do not reflect the views of the Heart Failure Society of America or the Journal of Cardiac Failure and all views expressed herein are those of the guests appearing on the show.

Dr. Bansilal was an Assistant Professor of Medicine at the Icahn School of Medicine at Mount Sinai when he decided to seek out an alternative pathway to make an impact on patients’ lives.

Dr. Ankur Kalra’s guest this week is Dr. Sameer Bansilal, Executive Director of U.S Medical Affairs of Cardiovascular and Renal at Bayer Pharmaceutical.

After years with the TIMI Study Group, Sameer made the decision to leave academic medicine to join the pharmaceutical industry. He was not alone with this career move; Dr. Jessica Mega had just joined Google Life Sciences and Dr. Laura Mauri became the Vice President of Medtronic. The image of being a physician at pharma was going through a change.

In this informative and honest conversation, Sameer shares his personal journey and the transformation that his new job required. Ankur and Sameer talk about expanding our views and our pilgrimage as readers. Ankur asks Sameer about the positive and negative aspects of his current job. Sameer addresses some of the preconceptions related to physicians working for the industry and shares his advice for early and mid-career cardiologists who are considering this option.

Questions and comments can be sent to “[email protected]” and may be answered by Ankur in the next episode. Guest @GarimaVSharmaMD, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Brought to you by Edwards: www.edwardstavr.com

Early in his career, Dr. Deepak L. Bhatt was considering becoming a basic science researcher. After an exchange with one of his mentors about doing science for the science’s sake, he had a self-realisation: He wanted his work to have a direct impact on patient care.

In the 50th episode of Parallax, Dr. Ankur Kalra’s guest is Dr. Deepak L. Bhatt leading physician, researcher, lecturer, and educator who has authored or co-authored over 1650 publications and was recipient of the ACC’s Distinguished Mentor Award in 2018 and AHA’s Distinguished Scientist Award in 2019.

In this candid and personal interview, Dr. Bhatt talks about the lessons he took away from being a proceduralist and how he applies them in his everyday life. Dr. Kalra asks Dr. Bhatt to share some of the housekeeping rules that guided him over the years. We learn more about the importance of mentorship and the people who shaped Dr. Bhatt. He reflects on what it means to be a physician and a researcher while he considers what makes scientific work impactful. Finally, Dr. Bhatt shares what he considers to be one of the most important personality traits of a good physician and/or researcher.

Questions and comments can be sent to “[email protected]” and may be answered by Ankur in the next episode. Guest @DLBHATTMD, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Brought to you by Edwards: www.edwardstavr.com

The American College of Cardiology surveyed cardiologists across the globe to have a more detailed understanding on the impact of hostility, discrimination, and harassment in the workplace. Of almost 6000 cardiologists who took part in the survey 44% reported hostile work environment.

Dr Ankur Kalra’s guest this week is Dr Garima Sharma, Director of CardioObstetrics and Assistant Professor of Medicine at the Johns Hopkins University as well as an investigator of the “Global Prevalence and Impact of Hostility, Discrimination, and Harassment in the Cardiology Workplace”.

According to Dr Sharma, the culture of a place is defined by what is tolerated. In this introspective and solution-seeking interview Garima explains how can microaggressions be identified and how does institutional culture normalise hostility by numbing the victims and making allowances for the perpetrators. In light of the data, they talk about the burden on early career cardiologists, and examine the role of institutions, senior faculty, and bystanders. Garima summarises the potential solutions and calls for making cardiology a viable option for all.

What is Dr Sharma’s take-home message from the ACC survey on hostile work environment? What could be the root causes of hostile behaviour? What are some of the solutions for work equity?

Questions and comments can be sent to “[email protected]” and may be answered by Ankur in the next episode. Guest @GarimaVSharmaMD, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.

Brought to you by Edwards: www.edwardstavr.com